HUMANA INC
HUMAPI behind this page
HUM Q1 2026 request
Playground key active
/api/financials?ticker=HUM&year=2026&quarter=1
Pick an endpoint and run the request.Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Premiums Earned Net | 37,709 | 30,514 | +23.6% |
Show Product Lines breakouts |
|||
| Product | 37,709 | 30,514 | +23.6% |
| Product · Insurance | 37,709 | 30,514 | +23.6% |
| Revenue From Contract With Customer Including Assessed Tax | 1,677 | 1,334 | +25.7% |
Show Product Lines breakouts |
|||
| Service | 1,677 | 1,334 | +25.7% |
| Service · CenterWell | 1,428 | 1,082 | +32.0% |
| Service · Corporate And Eliminations [Member] | 2 | — | — |
| Service · Insurance | 247 | 252 | -2.0% |
| Investment Income Interest And Dividend | 262 | 264 | -0.8% |
| Revenue | 39,648 | 32,112 | +23.5% |
Show Product Lines breakouts |
|||
| External Revenues | 39,386 | 31,848 | +23.7% |
| External Revenues · CenterWell | 1,428 | 1,082 | +32.0% |
| External Revenues · Corporate And Eliminations [Member] | 2 | — | — |
| External Revenues · Insurance | 37,956 | 30,766 | +23.4% |
Show Business Segments breakouts |
|||
| CenterWell · Corporate And Eliminations [Member] | 4,672 | 4,013 | +16.4% |
| CenterWell · Operating Segments | 6,100 | 5,095 | +19.7% |
| Insurance · Corporate And Eliminations [Member] | 1 | 1 | 0.0% |
| Insurance · Operating Segments | 38,059 | 30,937 | +23.0% |
Show Consolidation Items breakouts |
|||
| Corporate And Eliminations [Member] | -4,511 | -3,920 | -15.1% |
| Intersegment Elimination | -4,673 | -4,014 | -16.4% |
| Policyholder Benefits And Claims Incurred Net | 33,707 | 26,535 | +27.0% |
Show Business Segments breakouts |
|||
| Insurance · Operating Segments | 33,698 | 26,675 | +26.3% |
Show Consolidation Items breakouts |
|||
| Corporate And Eliminations [Member] | 9 | -140 | +106.4% |
| Selling, General & Administrative | 4,024 | 3,380 | +19.1% |
Show Business Segments breakouts |
|||
| CenterWell · Operating Segments | 5,762 | 4,644 | +24.1% |
| Insurance · Operating Segments | 2,784 | 2,534 | +9.9% |
Show Consolidation Items breakouts |
|||
| Corporate And Eliminations [Member] | -4,522 | -3,798 | -19.1% |
| Depreciation And Amortization | 163 | 183 | -10.9% |
Show Business Segments breakouts |
|||
| CenterWell · Operating Segments | 49 | 59 | -16.9% |
| Insurance · Operating Segments | 142 | 154 | -7.8% |
Show Consolidation Items breakouts |
|||
| Corporate And Eliminations [Member] | -28 | -30 | +6.7% |
| Benefits Losses And Expenses | 37,894 | 30,098 | +25.9% |
Show Business Segments breakouts |
|||
| CenterWell · Operating Segments | 5,811 | 4,703 | +23.6% |
| Insurance · Operating Segments | 36,624 | 29,363 | +24.7% |
Show Consolidation Items breakouts |
|||
| Corporate And Eliminations [Member] | -4,541 | -3,968 | -14.4% |
| Operating Income | 1,754 | 2,014 | -12.9% |
Show Business Segments breakouts |
|||
| CenterWell · Operating Segments | 289 | 392 | -26.3% |
| Insurance · Operating Segments | 1,435 | 1,574 | -8.8% |
Show Consolidation Items breakouts |
|||
| Corporate And Eliminations [Member] | 30 | 48 | -37.5% |
| Interest Expense | 193 | 160 | +20.6% |
| Other Non-Operating Income (Expense) | -34 | 163 | -120.9% |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | 1,595 | 1,691 | -5.7% |
| Income Tax Expense (Benefit) | 395 | 406 | -2.7% |
| Income Loss From Equity Method Investments | -16 | -43 | +62.8% |
| Net Income | 1,184 | 1,242 | -4.7% |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | -2 | -2 | 0.0% |
| Parent | 1,186 | 1,244 | -4.7% |
| Retained Earnings | 1,186 | 1,244 | -4.7% |
| Net Income Loss Attributable To Noncontrolling Interest | 2 | 2 | 0.0% |
| Net Income | 1,186 | 1,244 | -4.7% |
| EPS (Basic) | 9.85 | 10.31 | -4.5% |
| EPS (Diluted) | 9.83 | 10.3 | -4.6% |
| Comprehensive Income | 1,088 | 1,443 | -24.6% |
| Other Comprehensive Income | -98 | 199 | -149.2% |
| Wtd Avg Shares (Basic) | 120,332 | 120,666 | -0.3% |
| Wtd Avg Shares (Diluted) | 120,652 | 120,844 | -0.2% |
| Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 | 33,707 | 26,535 | +27.0% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 4,951 | 4,250 | +16.5% |
| Short-Term Investments | 17,014 | 17,888 | -4.9% |
| Receivables Net Current | 5,218 | 4,459 | +17.0% |
| Other Assets Current | 10,897 | 7,825 | +39.3% |
| Total Current Assets | 38,080 | 34,422 | +10.6% |
| Accounts Receivable (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Service | 324 | 365 | -11.2% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 2,170 | 2,427 | -10.6% |
| Available For Sale Securities Debt Securities Noncurrent | 626 | 410 | +52.7% |
| Goodwill | 10,489 | — | — |
Show Business Segments breakouts |
|||
| CenterWell | 7,608 | — | — |
| Insurance | 2,881 | — | — |
| Other Non-Current Assets | 3,282 | 3,381 | -2.9% |
| Total Assets | 55,280 | 50,930 | +8.5% |
| Intangible Assets (Q) | — | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Contractual Rights | 2 | 3 | -33.3% |
| Customer Contracts | 90 | 193 | -53.4% |
| Noncompetes and other | 29 | 32 | -9.4% |
| Trade Names | 15 | 19 | -21.1% |
| Other Assets | |||
| Equity Method Investments | 633 | 659 | -3.9% |
| Current Liabilities | |||
| Liability For Claims And Claims Adjustment Expense | 12,691 | 11,451 | +10.8% |
| Accounts Payable And Accrued Liabilities Current | 6,531 | 5,380 | +21.4% |
| Book Overdraft Liability | 297 | 370 | -19.7% |
| Deferred Revenue (Current) | 269 | 265 | +1.5% |
| Debt Current | 1,719 | 577 | +197.9% |
| Total Current Liabilities | 21,507 | 18,043 | +19.2% |
| Current Portion of Long-Term Debt (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| $600 million, 3.950% due March 15, 2027 · Senior Notes | 466 | — | — |
| $750 million, 1.350% due February 3, 2027 · Senior Notes | 553 | — | — |
Show Long-Term Debt Type breakouts |
|||
| Senior Notes | 1,019 | 577 | +76.6% |
| Non-Current Liabilities | |||
| Long-Term Debt | 12,274 | 12,729 | -3.6% |
Show Debt Instrument breakouts |
|||
| $1,000 million, 5.750% due April 15, 2054 · Senior Notes | 986 | 987 | -0.1% |
| $1,000 million, 6.625% due September 15, 2056 · Junior Subordinated Debt | 986 | — | — |
| $1,500 million, 5.375% due April 15, 2031 · Senior Notes | 1,487 | 1,485 | +0.1% |
| $250 million, 8.150% due June 15, 2038 · Senior Notes | 258 | 257 | +0.4% |
| $400 million, 4.625% due December 1, 2042 · Senior Notes | 371 | 375 | -1.1% |
| $400 million, 4.800% due March 15, 2047 · Senior Notes | 394 | 397 | -0.8% |
| $500 million, 3.950% due August 15, 2049 · Senior Notes | 513 | 514 | -0.2% |
| $500 million, 5.750% due December 1, 2028 · Senior Notes | 497 | 496 | +0.2% |
| $500 million, 5.750% due March 1, 2028 · Senior Notes | 491 | 490 | +0.2% |
| $500 million, 6.000% due May 1, 2055 · Senior Notes | 482 | 488 | -1.2% |
| $500 million, 3.125% due August 15, 2029 · Senior Notes | 388 | 434 | -10.6% |
| $500 million, 4.875% due April 1, 2030 · Senior Notes | 497 | 497 | 0.0% |
| $750 million, 3.700% due March 23, 2029 · Senior Notes | 586 | 586 | 0.0% |
| $750 million, 5.500% due March 15, 2053 · Senior Notes | 721 | 721 | 0.0% |
| $750 million, 5.550% due May 1, 2035 · Senior Notes | 742 | 743 | -0.1% |
| $750 million, 5.875% due March 1, 2033 · Senior Notes | 745 | 742 | +0.4% |
| $750 million, 2.150% due February 3, 2032 · Senior Notes | 592 | 744 | -20.4% |
| $750 million, 4.950% due October 1, 2044 · Senior Notes | 712 | 723 | -1.5% |
| $850 million, 5.950% due March 15, 2034 · Senior Notes | 826 | 822 | +0.5% |
| Other Non-Current Liabilities | 2,853 | 2,339 | +22.0% |
| Total Liabilities | 36,634 | 33,111 | +10.6% |
| Stockholders' Equity | |||
| Common Stock | 33 | 33 | 0.0% |
| Additional Paid In Capital Common Stock | 3,641 | 3,497 | +4.1% |
| Retained Earnings | 30,153 | 29,453 | +2.4% |
| Accumulated Other Comprehensive Income | -731 | -868 | +15.8% |
| Treasury Stock Common Value | -14,516 | -14,364 | -1.1% |
| Total Stockholders' Equity | 18,580 | 17,751 | +4.7% |
| Minority Interest | 66 | 68 | -2.9% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 18,646 | 17,819 | +4.6% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -731 | -868 | +15.8% |
| Additional Paid In Capital | 3,641 | 3,497 | +4.1% |
| Common Stock | 33 | 33 | 0.0% |
| Noncontrolling Interest | 66 | 68 | -2.9% |
| Parent | 18,580 | 17,751 | +4.7% |
| Retained Earnings | 30,153 | 29,453 | +2.4% |
| Treasury Stock Common | -14,516 | -14,364 | -1.1% |
| Total Liabilities & Equity | 55,280 | 50,930 | +8.5% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Debt And Equity Securities Gain Loss | 1 | -2 | +150.0% |
| Stock-Based Compensation | 51 | 49 | +4.1% |
| Depreciation | 183 | 200 | -8.5% |
| Adjustment For Amortization | 11 | 15 | -26.7% |
| Tangible Asset Impairment Charges | 2 | 9 | -77.8% |
| Increase Decrease In Receivables | -1,914 | -1,755 | -9.1% |
| Increase Decrease In Other Operating Assets | -1,390 | -686 | -102.6% |
| Increase Decrease In Health Care Insurance Liabilities | 2,724 | 1,011 | +169.4% |
| Increase Decrease In Other Operating Liabilities | 452 | 193 | +134.2% |
| Change in Deferred Revenue | -87 | 5 | -1840.0% |
| Other Operating Activities Cash Flow Statement | 21 | 7 | +200.0% |
| Net Cash from Operations | 1,254 | 331 | +278.9% |
| Investing Activities | |||
| Payments To Acquire Businesses Net Of Cash Acquired | 911 | — | — |
| Capital Expenditures | -121 | -95 | -27.4% |
| Purchases of Investments | -2,894 | -827 | -249.9% |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | 923 | 889 | +3.8% |
| Proceeds From Sale Of Available For Sale Securities Debt | 395 | 522 | -24.3% |
| Increase Decrease In Collateral Held Under Securities Lending | 55 | -175 | +131.4% |
| Net Cash from Investing | -2,553 | 314 | -913.1% |
| Fair Value Of Assets Acquired | 966 | — | — |
| Liabilities Assumed1 | -55 | — | — |
| Financing Activities | |||
| Payments For Proceeds From Contract Deposits | 673 | -35 | +2022.9% |
| Proceeds From Issuance Of Long Term Debt | 990 | 1,481 | -33.2% |
| Repayments Of Long Term Debt | -10 | — | — |
| Proceeds From Repayments Of Commercial Paper | 693 | -4 | +17425.0% |
| Increase Decrease In Book Overdrafts | -9 | -33 | +72.7% |
| Share Repurchases | -107 | -9 | -1088.9% |
| Payments Of Dividends | -107 | -108 | +0.9% |
| Increase Decrease In Securities Lending Payable | -55 | 175 | -131.4% |
| Proceeds From Payments For Other Financing Activities | -18 | -12 | -50.0% |
| Net Cash from Financing | 2,050 | 1,384 | +48.1% |
| Supplemental | |||
| Interest Paid | 142 | 143 | -0.7% |
| Income Taxes Paid | 7 | 12 | -41.7% |
| Other Cash Flow | |||
| Net Change in Cash | 751 | 2,029 | -63.0% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 4,951 | 4,250 | +16.5% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.